EDGAR Filing Documents for 0001193125-19-210934

Form 8-K - Current report:

SEC Accession No. 0001193125-19-210934

Filing Date

2019-08-01

Accepted

2019-08-01 16:31:56

Documents

Period of Report

2019-07-26

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d778590d8k.htm	8-K	26458
2	EX-4.1	d778590dex41.htm	EX-4.1	59609
3	EX-10.1	d778590dex101.htm	EX-10.1	100659
4	EX-10.2	d778590dex102.htm	EX-10.2	137402
5	EX-10.3	d778590dex103.htm	EX-10.3	101368
6	EX-99.1	d778590dex991.htm	EX-99.1	10181
7	GRAPHIC	g778590g0731091744268.jpg	GRAPHIC	4044
	Complete submission text file	0001193125-19-210934.txt		442760

Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129

Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 617-259-1970

ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)